Alnylam Pharmaceuticals
ALNY
#525
Rank
C$60.82 B
Marketcap
C$458.59
Share price
0.82%
Change (1 day)
14.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Cost to borrow ALNY shares - Alnylam Pharmaceuticals

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.2769% (annualized)

Shares available to borrow: 1300000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2026 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Novartis
NVS
0.4027%0.55 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
0.4081%1.4 M๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
0.4081%1.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.3594%2.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
3.5647%2.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
0.3711%1.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0.2724%6.3 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
0.2891%1.3 M๐Ÿ‡บ๐Ÿ‡ธ USA